Strides Pharma Science gets nod for divestment of Australian Business
28th Mar 2019

Strides Pharma Science has received an approval from the shareholders for divestment of Australian Business and for Transactions/ Contracts/ Arrangements with Solara Active Pharma Sciences up to Rs 500 crore in each financial year, commencing from FY 2018-19.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.